Heparin-induced thrombocytopenia: A common complication in cardiac transplant recipients

Journal of Heart and Lung Transplantation

Volumn 21, Issue 12, 2002, Pages 1283-1289

  Hourigan, Lisa A ^a   Walters, Darren L ^a   Keck, Sally A ^a   Dec, G William ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ARGATROBAN; DALTEPARIN; HEPARIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LEPIRUDIN;

ADULT; AGED; ANTIBODY DETECTION; ANTICOAGULATION; ARTERY EMBOLISM; ARTICLE; BLEEDING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY; DATA BASE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL VEIN; HEART FAILURE; HEART INFARCTION; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; JUGULAR VEIN; KIDNEY ARTERY STENOSIS; KIDNEY INFARCTION; LUNG EMBOLISM; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLEEN INFARCTION; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BLOOD COAGULATION TESTS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART TRANSPLANTATION; HEPARIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0036916631     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00458-8     Document Type: Article

References (20)

1. Warkentin T.E., Levine M.N., Hirsh J., et al. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin. N Engl J Med. 332:1995;1330-1335.
2. Warkentin T.E. Clinical picture of heparin-induced thrombocytopenia. Warkentin T.E., Grinacher A. Heparin-induced Thrombocytopenia. 2000;48-80 Marcel Dekker, New York.
3. Warkentin T.E., Kelton J.G. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 344:2001;1286-1292.
4. Januzzi J.L., Jang I.-K. Fundamental concepts in the pathobiology of heparin-induced thrombocytopenia. J Thromb Thrombolysis. 10:2000;S7-11.
5. Admiral J., Bridey F., Dreyfus M., et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 68:1992;95-96.
6. Newman P.M., Choong B.H. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood. 96:2000;182-187.
7. Spencer F.A. Heparin-induced thrombocytopenia: patient profiles and clinical manifestations. J Thromb Thrombolysis. 10:2000;S21-25.
8. Warkentin T.E., Kelton J.G. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 101:1996;502-507.
9. Rhodes G.R., Dixon R.H., Silver D. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstret. 136:1973;409-416.
10. Walenga J.M., Jeske W.P., Messmore H.L. Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia. J Thromb Thrombolysis. 10:2000;S13-20.
11. Kadidal V.V., Mayo D.J., Horne M.K. Heparin-induced thrombocytopenia (HIT) due to heparin line flushes a report of three cases. J Intern Med. 246:1999;325-329.
12. Warkentin T.E. Laboratory testing for heparin-induced thrombocytopenia. J Thromb Thrombolysis. 10:2000;S35-45.
13. Chang J.C. White clot syndrome associated with heparin-induced thrombocytopenia a review of 23 cases. Heart Lung. 16:1987;403-407.
14. Warkentin T.E. Heparin-induced skin lesions. Br J Haematol. 92:1996;494-497.
15. Warkentin T.E., Hirte H.W., Anderson D.R., et al. Transient global amnesia associated with acute heparin-induced thrombocytopenia. Am J Med. 97:1994;489-491.
16. Ernest D., Fisher M.M. Heparin-induced thrombocytopenia complicated by bilateral adrenal hemorrhage. Intensive Care Med. 17:1991;238-240.
17. Wallis D.E., Workman D.L., Lewis B.E., Steen L., Pifarre R., Moran J.F. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med. 106:1999;629-635.
18. Lubenow N., Greinacher A. Management of patients with heparin-induced thrombocytopenia focus on recombinant hirudin. J Thromb Thrombolysis. 10:2001;S47-57.
19. Greinacher A., Lubenow N. Recombinant hirudin in clinical practice. Focus on lepirudin. Circulation. 103:2001;1479-1484.
20. Lewis B.E., Wallis D.E., Berkowitz S.D., et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation. 103:2001;1838-1843.